Fluvoxamine Maleate

Records for this ingredient, by country (identity only).

ATC N06AB08 · 4 markets · 23 records

Fluvoxamine Maleate 4 markets · 23 records Forms

Filters

MarketAU 10 HK 4 FR 4 SG 3

Strength

AU 10 records · 2 shown of 2 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

100 mgtabletAPO-FLUVOXAMINE fluvoxamine maleate 50 mg tablet blister pack+4FAVERIN fluvoxamine maleate 100mg tablet blister pack、Fluvoxamine-WGR fluvoxamine maleate 50 mg tablet blister pack、LUVOX fluvoxamine maleate 50mg tablet blister pack、MOVOX fluvoxamine maleate 50mg tablet blister pack also in FR·SG unknown
50 mgtabletAPO-FLUVOXAMINE fluvoxamine maleate 50 mg tablet blister pack+4FAVERIN 50 fluvoxamine maleate 50mg tablet blister pack、Fluvoxamine-WGR fluvoxamine maleate 50 mg tablet blister pack、LUVOX fluvoxamine maleate 50mg tablet blister pack、MOVOX fluvoxamine maleate 50mg tablet blister pack also in FR·SG unknown

HK 4 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名APO-Fluvoxamine ×10Faverin 50mg tablets ×8

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 4 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

100 mgtabletFLOXYFRAL 100 mg, comprimé pelliculé sécable+1FLUVOXAMINE ARROW 100 mg, comprimé pelliculé sécable also in AU·SG
50 mgtabletFLOXYFRAL 100 mg, comprimé pelliculé sécable+1FLUVOXAMINE ARROW 100 mg, comprimé pelliculé sécable also in AU·SG

SG 3 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

100 mgtabletAPO-Fluvoxamine+1FAVERIN TABLET 100 mg (WHITE) also in AU·FR
50 mgtabletFAVERIN TABLET 100 mg (WHITE) also in AU·FR

Side-by-side table

Strength / form / release	AU	SG	HK	FR
100 mg tablet	APO-FLUVOXAMINE fluvoxamine maleate 50 mg tablet blister pack FAVERIN fluvoxamine maleate 100mg tablet blister pack Fluvoxamine-WGR fluvoxamine maleate 50 mg tablet blister pack +2 LUVOX fluvoxamine maleate 50mg tablet blister pack MOVOX fluvoxamine maleate 50mg tablet blister pack	APO-Fluvoxamine FAVERIN TABLET 100 mg (WHITE)	not recorded	FLOXYFRAL 100 mg, comprimé pelliculé sécable FLUVOXAMINE ARROW 100 mg, comprimé pelliculé sécable
50 mg tablet	APO-FLUVOXAMINE fluvoxamine maleate 50 mg tablet blister pack FAVERIN 50 fluvoxamine maleate 50mg tablet blister pack Fluvoxamine-WGR fluvoxamine maleate 50 mg tablet blister pack +2 LUVOX fluvoxamine maleate 50mg tablet blister pack MOVOX fluvoxamine maleate 50mg tablet blister pack	FAVERIN TABLET 100 mg (WHITE)	not recorded	FLOXYFRAL 100 mg, comprimé pelliculé sécable FLUVOXAMINE ARROW 100 mg, comprimé pelliculé sécable
not disclosed unknown	not recorded	not recorded	APO-Fluvoxamine Faverin 50mg tablets	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in HK and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK 有记录（未在本表显示）。另有 1 個規格/劑型僅在 HK 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.